AVITA Medical, Inc. (RCEL)
12.72
+0.71
(+5.91%)
USD |
NASDAQ |
Oct 02, 16:00
12.66
-0.06
(-0.51%)
After-Hours: 20:00
AVITA Medical Market Cap : 393.39M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 393.39M |
| October 01, 2026 | 371.43M |
| September 30, 2026 | 362.77M |
| September 29, 2026 | 369.88M |
| September 28, 2026 | 360.92M |
| September 25, 2026 | 366.17M |
| September 24, 2026 | 358.13M |
| September 23, 2026 | 338.65M |
| September 22, 2026 | 355.35M |
| September 21, 2026 | 335.25M |
| September 18, 2026 | 340.81M |
| September 17, 2026 | 347.00M |
| September 16, 2026 | 323.19M |
| September 15, 2026 | 315.76M |
| September 14, 2026 | 315.14M |
| September 11, 2026 | 305.56M |
| September 10, 2026 | 304.94M |
| September 09, 2026 | 314.22M |
| September 08, 2026 | 321.95M |
| September 04, 2026 | 346.38M |
| September 03, 2026 | 338.34M |
| September 02, 2026 | 332.77M |
| September 01, 2026 | 311.43M |
| August 31, 2026 | 312.36M |
| August 28, 2026 | 320.09M |
| Date | Value |
|---|---|
| August 27, 2026 | 319.16M |
| August 26, 2026 | 327.51M |
| August 25, 2026 | 324.73M |
| August 24, 2026 | 306.48M |
| August 21, 2026 | 311.12M |
| August 20, 2026 | 312.05M |
| August 19, 2026 | 319.78M |
| August 18, 2026 | 304.63M |
| August 17, 2026 | 244.32M |
| August 14, 2026 | 242.78M |
| August 13, 2026 | 247.72M |
| August 12, 2026 | 251.13M |
| August 11, 2026 | 253.60M |
| August 10, 2026 | 235.04M |
| August 07, 2026 | 240.30M |
| August 06, 2026 | 146.90M |
| August 05, 2026 | 138.24M |
| August 04, 2026 | 143.19M |
| August 03, 2026 | 142.19M |
| July 31, 2026 | 135.42M |
| July 30, 2026 | 138.19M |
| July 29, 2026 | 136.65M |
| July 28, 2026 | 141.88M |
| July 27, 2026 | 146.19M |
| July 24, 2026 | 141.88M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 12.53B |
| Iovance Biotherapeutics, Inc. | 6.439B |
| Amgen, Inc. | 217.88B |
| Editas Medicine, Inc. | 402.25M |
| Arcus Biosciences, Inc. | 3.104B |
Market Cap Related Metrics
| PS Ratio | 5.048 |
| Price | 12.72 |
| Earnings Yield | -11.35% |